Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
CMS Initiatives Regarding Pain-Management Issues
In 2018, CMS adopted a three-pronged approach to the public-health emergency posed by opioid use.
Management of Acute Ischemic Stroke: a Review of Pertinent Guideline Updates
There have been significant evidence-based literature updates regarding the management of acute ischemic stroke (AIS) in adult patients; these are discussed in a 2018 guideline update.
Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors
This drug class confers benefits in diabetic patients with heart failure, CV disease, and renal disease, but it is also associated with major adverse events.
Worsening Overdose Crisis Predicted
Opioid-related research developments of interest to pharmacists.
Aripiprazole 1 mg/mL Oral Suspension
This may be suitable for patients who cannot take the solid oral dosage forms or tolerate the ingredients in the commercially available oral solution.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.